Pocharapong Jenjitranant
Papers
6
Total Citations
137
H-Index
5
About
Dr. Pocharapong Jenjitranant is a pioneering urologic surgeon and researcher whose work focuses on advancing minimally invasive surgical techniques for prostate and kidney cancers, with a particular emphasis on improving outcomes for complex patient populations. His most impactful contribution is the LuTectomy trial (84 citations), a landmark phase 1/2 study that investigated administering [177Lu]Lu-PSMA-617 prior to radical prostatectomy in men with high-risk localized prostate cancer—a novel theranostic approach bridging nuclear medicine and surgery. Dr. Jenjitranant has also made significant contributions to comparative effectiveness research, including a comprehensive 10-year analysis of partial nephrectomy techniques (17 citations) demonstrating superior trifecta outcomes for robotic-assisted approaches, and a similar comparison of radical prostatectomy modalities (16 citations) that helped establish robotic surgery as the standard at Ramathibodi Hospital. Notably, he performed the first Retzius-sparing robotic prostatectomy in a kidney transplant patient in Thailand (12 citations), showcasing his expertise in navigating surgically complex cases. His work on radical prostatectomy outcomes in renal transplant recipients (6 citations) further underscores his dedication to optimizing cancer care in immunocompromised patients. Through his innovative research and surgical leadership, Dr. Jenjitranant continues to shape the evolution of urologic oncology in Thailand and beyond.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6Robotic partial nephrectomy for hilar renal masses2 citations · 2021